Advanced glycation end products-induced vascular calcification is mediated by oxidative stress: Functional roles of NAD(P)H-oxidase

Hormone and Metabolic Research

Volumn 45, Issue 4, 2013, Pages 267-272

  Tada, Y ^a   Yano, S ^a   Yamaguchi, T ^a   Okazaki, K ^a   Ogawa, N ^a   Morita, M ^a   Sugimoto, T ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

diabetes; NADPH oxidase; oxidative stress; vascular calcification; vascular smooth muscle

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ADVANCED GLYCATION END PRODUCT; CALCIUM; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; PROTEIN P22; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BLOOD VESSEL CALCIFICATION; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; MINERALIZATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; RATS; VASCULAR CALCIFICATION;

RATTUS;

EID: 84876855691     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1329965     Document Type: Article

References (46)

1. Mönckeberg J. Uber die reine Mediaverkalkung der Extremitätenarterien und ihr Verhalten zur Arteriosklerose. Virchows Arch Pathol Anat: 1902; 171 141 167
2. Edmonds M. E., Morrison N., Laws J. W., Watkins P. J. Medial arterial calcification and diabetic neuropathy. Br Med J: 1982; 284 928 930 (Pubitemid 12192941)
3. Guerin A. P., London G. M., Marchais S. J., Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant: 2000; 15 1014 1021 (Pubitemid 30410374)
4. Blacher J., Guerin A. P., Pannier B., Marchais S. J., London G. M. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension: 2001; 38 938 942 (Pubitemid 34258697)
5. London G. M., Guerin A. P., Marchais S. J., Métivier F., Pannier B., Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant: 2003; 18 1731 1740 (Pubitemid 37098542)
6. Detrano R., Guerci A. D., Carr J. J., Bild D. E., Burke G., Folsom A. R., Liu K., Shea S., Szklo M., Bluemke D. A., O'Leary D. H., Tracy R., Watson K., Wong N. D., Kronmal R. A. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New Engl J Med: 2008; 358 1336 1345 (Pubitemid 351468410)
7. Lehto S., Niskanen L., Suhonen M., Ronnemaa T., Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol: 1996; 16 978 983
8. Goodman W. G., Goldin J., Kuizon B. D., Yoon C., Gales B., Sider D., Wang Y., Chung J., Emerick A., Greaser L., Elashoff R. M., Salusky I. B. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. New Engl J Med: 2000; 342 1478 1483 (Pubitemid 30318271)
9. Giachelli C. M. The emerging role of phosphate in vascular calcification. Kidney Int: 2009; 75 890 897
10. Shioi A., Katagi M., Okuno Y., Mori K., Jono S., Koyama H., Nishizawa Y. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res: 2002; 91 9 16 (Pubitemid 34778936)
11. Speer M. Y., Chien Y. C., Quan M., Yang H. Y., Vali H., McKee M. D., Giachelli C. M. Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovasc Res: 2005; 66 324 333 (Pubitemid 40471047)
12. Katsuda S., Okada Y., Minamoto T., Oda Y., Matsui Y., Nakanishi I. Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. Arterioscler Thromb: 1992; 12 494 502
13. Mody N., Parhami F., Sarafian T. A., Demer L. L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med: 2001; 31 509 519 (Pubitemid 32728438)
14. Byon C. H., Javed A., Dai Q., Kappes J. C., Clemens T. L., Darley-Usmar V. M., McDonald J. M., Chen Y. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem: 2008; 283 15319 15327
15. Yamagishi S., Imaizumi T. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des: 2005; 11 2279 2299 (Pubitemid 40872698)
16. Sekido H., Suzuki T., Jomori T., Takeuchi M., Yabe-Nishimura C., Yagihashi S. Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells. Biochem Biophys Res Commmun: 2004; 320 241 248 (Pubitemid 38781807)
17. Yamagishi S., Amano S., Inagaki Y., Okamoto T., Koga K., Sasaki N., Yamamoto H., Takeuchi M., Makita Z. Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes. Biochem Biophys Res Commmun: 2002; 290 973 978 (Pubitemid 34687457)
18. Yamagishi S., Inagaki Y., Okamoto T., Amano S., Koga K., Takeuchi M., Makita Z. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem: 2002; 277 20309 20315 (Pubitemid 34967325)
19. Tan K. C., Chow W. S., Ai V. H., Metz C., Bucala R., Lam K. S. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes care: 2002; 25 1055 1059 (Pubitemid 41110493)
20. Nakayama K., Nakayama M., Iwabuchi M., Terawaki H., Sato T., Kohno M., Ito S. Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients. Am J Nephrol: 2008; 28 871 878
21. Brownlee M. Advanced protein glycosylation in diabetes and aging. Ann Rev Med: 1995; 46 223 234
22. Basta G., Lazzerini G., Del Turco S., Ratto G. M., Schmidt A. M., De Caterina R. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol: 2005; 25 1401 1407 (Pubitemid 40923359)
23. Goldin A., Beckman J. A., Schmidt A. M., Creager M. A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation: 2006; 114 597 605 (Pubitemid 44199649)
24. Coughlan M. T., Thorburn D. R., Penfold S. A., Laskowski A., Harcourt B. E., Sourris K. C., Tan A. L., Fukami K., Thallas-Bonke V., Nawroth P. P., Brownlee M., Bierhaus A., Cooper M. E., Forbes J. M. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. J Am Soc Nephrol: 2009; 20 742 752
25. Chen N. X., Duan D., O'Neill K. D., Moe S. M. High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant: 2006; 21 3435 3442 (Pubitemid 44817092)
26. Ren X., Shao H., Wei Q., Sun Z., Liu N. Advanced glycation end-products enhance calcification in vascular smooth muscle cells. J Int Med Res: 2009; 37 847 854
27. Tanikawa T., Okada Y., Tanikawa R., Tanaka Y. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J Vasc Res: 2009; 46 572 580
28. Shioi A., Nishizawa Y., Jono S., Koyama H., Hosoi M., Morii H. Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol: 1995; 15 2003 2009
29. Ogawa N., Yamaguchi T., Yano S., Yamauchi M., Yamamoto M., Sugimoto T. The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs. Horm Metab Res: 2007; 39 871 875
30. Yano S., Yamaguchi T., Kanazawa I., Ogawa N., Hayashi K., Yamauchi M., Sugimoto T. The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure. Nephrol Dial Transplant: 2007; 22 3160 3165 (Pubitemid 350202573)
31. Shao J. S., Sierra O. L., Cohen R., Mecham R. P., Kovacs A., Wang J., Distelhorst K., Behrmann A., Halstead L. R., Towler D. A. Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis. Arterioscler Thromb Vasc Biol: 2011; 31 1821 1833
32. Shao J. S., Cheng S. L., Pingsterhaus J. M., Charlton-Kachigian N., Loewy A. P., Towler D. A. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest: 2005; 115 1210 1220 (Pubitemid 40629039)
33. Parhami F., Morrow A. D., Balucan J., Leitinger N., Watson A. D., Tintut Y., Berliner J. A., Demer L. L. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol: 1997; 17 680 687 (Pubitemid 27169128)
34. San Martin A., Du P., Dikalova A., Lassègue B., Aleman M., Góngora M. C., Brown K., Joseph G., Harrison D. G., Taylor W. R., Jo H., Griendling K. K. Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am J Physiol Heart Circ Physiol: 2007; 292 H2073 H2082 (Pubitemid 47084581)
35. Hata I., Kaji M., Hirano S., Shigematsu Y., Tsukahara H., Mayumi M. Urinary oxidative stress markers in young patients with type 1 diabetes. Pediatr Int: 2006; 48 58 61
36. Suh Y. A., Arnold R. S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A. B., Griendling K. K., Lambeth J. D. Cell transformation by the superoxide-generating oxidase Mox1. Nature: 1999; 401 79 82
37. Lassegue B., Sorescu D., Szöcs K., Yin Q., Akers M., Zhang Y., Grant S. L., Lambeth J. D., Griendling K. K. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res: 2001; 88 888 894 (Pubitemid 32441466)
38. Fukui T., Lassegue B., Kai H., Alexander R. W., Griendling K. K. Cytochrome b-558 alpha-subunit cloning and expression in rat aortic smooth muscle cells. Biochim Biophys Acta: 1995; 1231 215 219
39. Bleeke T., Zhang H., Madamanchi N., Patterson C., Faber J. E. Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res: 2004; 94 37 45 (Pubitemid 38064096)
40. Ellmark S. H., Dusting G. J., Fui M. N., Guzzo-Pernell N., Drummond G. R. The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Cardiovasc Res: 2005; 65 495 504 (Pubitemid 40082491)
41. Gorlach A., Brandes R. P., Bassus S., Kronemann N., Kirchmaier C. M., Busse R., Schini-Kerth V. B. Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets. FASEB J: 2000; 14 1518 1528 (Pubitemid 30636556)
42. Khatri J. J., Johnson C., Magid R., Lessner S. M., Laude K. M., Dikalov S. I., Harrison D. G., Sung H. J., Rong Y., Galis Z. S. Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation: 2004; 109 520 525 (Pubitemid 38168516)
43. Zhang M., Brewer A. C., Schröder K., Santos C. X., Grieve D. J., Wang M., Anilkumar N., Yu B., Dong X., Walker S. J., Brandes R. P., Shah A. M. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci USA: 2010; 42 18121 18126
44. Kim Y. K., Lee M. S., Son S. M., Kim I. J., Lee W. S., Rhim B. Y., Hong K. W., Kim C. D. Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes: 2002; 51 522 527 (Pubitemid 34764812)
45. Etoh T., Inoguchi T., Kakimoto M., Sonoda N., Kobayashi K., Kuroda J., Sumimoto H., Nawata H. Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibility by interventive insulin treatment. Diabetologia: 2003; 46 1428 1437 (Pubitemid 37297214)
46. Serrander L., Cartier L., Bedard K., Banfi B., Lardy B., Plastre O., Sienkiewicz A., Fórró L., Schlegel W., Krause K. H. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J: 2007; 406 105 114 (Pubitemid 47264740)